Long-term treatment of multiple sclerosis with azathioprine.
Nineteen patients with multiple sclerosis were treated with azathioprine for two years. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 24 control patients observed over the same period.
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001806:Blood Urea Nitrogen; D001933:Brain Stem / Q000187:drug effects; D002531:Cerebellum / Q000187:drug effects; D005069:Evaluation Studies as Topic; D006801:Humans; D008111:Liver Function Tests; D008134:Long-Term Care; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011712:Pyramidal Tracts / Q000187:drug effects; D012008:Recurrence; D001743:Urinary Bladder / Q000187:drug effects; D014792:Visual Acuity / Q000187:drug effects
D001379:Azathioprine